Document
The Drug Enforcement Administration (DEA) published a document in the Federal Register on August 12, 2021, concerning a notice of application. The document indicated the approve...
Drug Enforcement Administration, Justice.
Notice of application; correction.
The Drug Enforcement Administration (DEA) published a document in the Federal Register on August 12, 2021, concerning a notice of application. The document indicated the approved drug code (1205—Lisdexamfetamine) as a schedule I. The correct drug schedule should read schedule II.
In the Federal Register of August 12, 2021, in FR Doc. 2021-17181 (86 FR 44405), on page 44406, in the first column, in the controlled substance table, correct the drug schedule to schedule II.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2022-00852 Filed 1-21-22; 8:45 am]
BILLING CODE P
Legal Citation
Use this for formal legal and research references to the published document.
87 FR 3587
Web Citation
Use this when citing the archival web version of the document.
“Importer of Controlled Substances Application: Globyz Pharma, LLC; Correction,” thefederalregister.org (January 24, 2022), https://thefederalregister.org/documents/2022-00852/importer-of-controlled-substances-application-globyz-pharma-llc-correction.